Table 5.
IgA [μg/ml] | IL-6 [pg/ml] | |
---|---|---|
Group1 | ||
0-DLML | 0.176 | 0.141b |
0-MHAL | 0.096 | 0.161b |
0-DLMH | 0.159 | 0.121bc |
0-MHAH | 0.278 | 0.118bc |
HE-DLML | 0.178 | 0.385a |
HE-MHAL | 0.086 | 0.101bc |
HE-DLMH | 0.101 | 0.201b |
HE-MHAH | 0.103 | 0.070c |
Infection | ||
0 | 0.177 | 0.135 |
HE | 0.117 | 0.189 |
Met dosage | ||
Low | 0.134 | 0.197 |
High | 0.160 | 0.127 |
Met source | ||
DLM | 0.153 | 0.212 |
MHA | 0.141 | 0.113 |
SEM2 | 0.012 | 0.017 |
p – values | ||
Infection | < 0.001 | < 0.001 |
Dose | 0.068 | < 0.001 |
Source | 0.414 | < 0.001 |
Interactions | nd3 | d4 |
1 Feeds administered to uninfected (0) and infected (HE) turkeys in weeks 1–4 and 5–8, contained DLM and the equivalent amount of MHA at two levels low (L) - 0.55, 0.45, and high (H) - 0.78, 0.65, respectively [% as fed]
2SEM- standard error of the mean
3nd – not detected: no significant infection x dose, infection x source, dose x source or infection x dose x source interactions
4d- detected: Significant interactions between the experimental factors; higher dose of DLM and both doses of MHA decreased plasma IL-6 levels in HEV-infected turkeys
a-c values differ significantly